Max Healthcare share price closes at session high of ₹928.30; gains 1.45%
Anshul Mishra
- 0 min read
Last Updated: 11th November 2026 - 05:17 pm
Key Takeaways
Max Healthcare finished at its session high of ₹928.30, gaining 1.45%, after opening at ₹918 and touching ₹915.
The close was just ₹2 below the 50-day DMA but remained ₹80.40 below the 200-day DMA of ₹1,008.70.
One-month performance was positive at 5.04%, while three-month, six-month and one-year returns were all negative.
Max Healthcare Institute share price closed November 11 at ₹928.30, gaining ₹13.30 or 1.45%. The stock opened at ₹918 against a previous close of ₹915. It traded as low as ₹915 before reaching ₹928.30, which also became the closing price. The ₹13.30 range therefore ended with the stock exactly at its session high and ₹10.30 above the opening level.
Volume reached 1,837,657 shares. The market price finished very close to the 50-day DMA but remained further below the two longer averages. The 50-day DMA stood at ₹930.30, only ₹2 above the close. The 100-day DMA was ₹971, while the 200-day DMA stood at ₹1,008.70. Max Healthcare therefore remained ₹80.40 below the 200-day figure.
The 52-week low was ₹797 and the high ₹1,185. The November 11 close was ₹131.30 above the annual low and ₹256.70 below the high. The annual range spanned ₹388.
Return figures were positive only over one month. That period showed a 5.04% gain, while the three-month return was -13.16%. Six-month performance stood at -8.32%, and the one-year return was -15.46%. The spread between one-month and one-year readings reached 20.50 percentage points. The day's finish at the session high contrasted with a closing value still below all three moving averages, albeit only narrowly below the 50-day DMA.
Frequently Asked Questions
What was the Max Healthcare share price on November 11?
How close was Max Healthcare to its 50-day DMA?
What was Max Healthcare's three-month return?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.